Campylobacter jejuni infection as a cause of the Guillain-Barre syndrome

Infectious Disease Clinics of North America

Volumn 12, Issue 1, 1998, Pages 173-184

  Allos, B M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GANGLIOSIDE;

CAMPYLOBACTER JEJUNI; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; MOLECULAR MIMICRY; PERIPHERAL NERVE; REVIEW;

EID: 0031896272     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70416-5     Document Type: Article

References (102)

1. B.M. Allos Association between Campylobacter jejuni infection and Guillain-Barré syndrome J Infect Dis 1997 in press
2. K. Araski S. Kusunoki N. Kudo Acute conduction block in vitro following exposure to antiganglioside sera Muscle Nerve 16 1993 587 593
3. G.O. Aspinall S. Fujimoto A.G. McDonald Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome in patients mimic human gangliosides in structure Infect Immun 62 1994 2122 2125
4. G.O. Aspinall A.G. McDonald H. Pang Lipopolysaccharides of Campylobacter jejuni serotype O:19 structure of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with Guillain-Barre syndrome Biochem 33 1994 241 249
5. G.O. Aspinall A.G. McDonald T.S. Raju Serologic diversity and chemical structures of Campylobacter jejuni low molecular-weight serotype lipopolysaccharides J Bacteriol 174 1992 1324 1332
6. G.O. Aspinall A.G. McDonald T.S. Raju Chemical structure of the core regions of Campylobacter jejuni sterotype O:1, O:4, O:23, and O:36 lipopolysaccharides Eur J Biochem 213 1993 1017 1027
7. E. Bech T.F. Orntoft L.P. Anderson IgM anti-GM1 antibodies in the Guillain-Barre syndrome: a serological predictor of the clinical course J Neuroimmunol 72 1997 59 66
8. M.J. Blaser I.D. Berkowitz M. LaForce Campylobacter enteritis: Clinical and epidemiologic features Ann Intern Med 91 1979 179 185
9. M.J. Blaser D.J. Duncan Human serum antibody response to Campylobacter jejuni infection as measured by enzyme-linked immunosorbent assay Infect Immun 44 1984 292 298
10. M.J. Blaser J.G. Wells R.A. Feldman Campylobacter enteritis in the United States: A multicenter study Ann Intern Med 98 1983 360 365
11. J.G. Breman J.S. Hayner Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976–1977 Am J Epidemiol 119 1984 880 889
12. T. Bremell A. Bjelle A. Svedhem Rheumatic symptoms following an outbreak of campylobacter enteritis: A 5 year follow up Ann Rheum Dis 50 1991 934 938
13. A.M.G. Campbell The aetiology of polyneuritis Proc R Soc Med 51 1958 157 159
14. A. Chiba S. Kusonoki T. Shimizu Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome Ann Neurol 31 1992 677 679
15. C.J. Coe Guillain-Barré syndrome in Korean children Yonseri Med J 30 1989 81 87
16. O.C. Constant C.C. Bentley A.M. Denman The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis J Infect 6 1983 89 91
17. M. Corbo A. Quattrini N. Latov Localization of GM1 and Gal( B 1-3)GalNAc antigenic determinants in peripheral nerve Neurology 43 1993 809 814
18. D.L.W. Davidson A.F. O'Sullivan K.D. Morley HLA antigens in familial Guillain-Barré syndrome J Neurol Neurosurg Psychiatry 55 1992 508 509
19. A.E. de Jager H.J. Sluiter Clinical signs in severe Guillain-Barré syndrome: Analysis of 63 patients J Neurol Sci 104 1991 143 150
20. M.S. Deming R.V. Tauxe P.A. Blake Campylobacter enteritis at a university: Transmission from eating chicken and from cats Am J Epidemiol 126 1987 526 534
21. P.C. Dowling Role of infection in Guillain-Barré syndrome: Laboratory confirmation of herpesviruses in 41 cases Ann Neurol 9 suppl 1981 44 55
22. P.C. Dowling J.P. Menonna S.D. Cook Guillain-Barré syndrome in greater New York-New Jersey JAMA 238 1977 317 318
23. U. Enders H. Karch K.V. Toyka Campylobacter jejuni and Guillain-Barré syndrome Ann Neurol 35 1994 249
24. U. Enders H. Karch K.V. Toyka The spectrum of immune responses to C. jejuni and glycoconjugates in Guillain-Barré syndrome and in other neurologic disorders Ann Neurol 34 1993 136 144
25. S. Fujimoto B.M. Allos N. Misawa Restriction fragment length polymorphism analysis and random amplified polymorphic DNA analysis of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome J Infect Dis 176 1997 1105 1108
26. S. Fujimoto N. Yuki T. Itoh Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome J Infect Dis 165 1992 183
27. N.A. Gregson J.H. Rees R.A.C. Hughes Reactivity of serum IgG and anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome (GBS) J Neuroimmunol 73 1997 28 36
28. N.A. Gregson S. Koblar R.A.C. Hughes Antibodies to gangliosides in Guillain-Barré syndrome: Specificity and relationship to clinical features Q J Med 86 1993 111 117
29. R. Gruenwald A.H. Ropper H. Lior Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain-Barré syndrome Arch Neurol 48 1991 1080 1082
30. H. Hariharan C. Naseema J. Shanmugam Detection of Campylobacter jejuni/Campylobacter coli infection in patients with Guillain-Barré syndrome by serology and culture N Microbiologica 19 1996 267 271
31. J. Hillert P.O. Osterman O. Olerup No association with HLA-DR, -DQ, or -DP alleles in Guillain-Barré syndrome J Neuroimmunol 31 1991 67 72
32. T.W. Ho B. Mishu C.Y. Li Guillain-Barré syndrome in northern China: Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies Brain 118 1995 597 605
33. R.A.C. Hughes Guillain-Barré Syndrome 1991 Springer-Verlag London
34. E.S. Hurwitz R.C. Holman D.B. Nelson National surveillance for Guillain-Barré syndrome: January 1978-March 1979 Neurology 33 1983 150 157
35. I. Illa N. Ortiz E. Gallard Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides Ann Neurol 38 1995 218 224
36. A.A. Ilyas F.A. Mithen Z. Chen Anti-GM1 IgA antibodies in Guillain-Barré syndrome J Neuroimmunol 36 1992 69 76
37. A.A. Ilyas H.J. Willison R.H. Quarles Serum antibodies to gangliosides in Guillain-Barré syndrome Ann Neurol 23 1988 440 447
38. B.C. Jacobs M.P. Hazenberg P.A. van Doorn Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré syndrome or Miller Fisher syndrome J Infect Dis 175 1997 729 733
39. J. Kaldor B.R. Speed Guillain-Barré syndrome and Campylobacter jejuni Br Med J 288 1984 1867 1870
40. R.H. Kennedy M.A. Danielson D.W. Mulder Guillain-Barré syndrome: A 42-year epidemiologic and clinical study Mayo Clin Proc 53 1978 93 99
41. S.H. Khoury Guillain-Barré syndrome: Epidemiology of an outbreak Am J Epidemiol 107 1978 433 438
42. E.O. King Human infections with Vibrio fetus and a closely related vibrio J Infect Dis 101 1957 119 128
43. S. Kuroki T. Saida M. Nukina Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain B-N-Acetylglucosamine Ann Neurol 22 1993 243 247
44. A.J. Lastovica E.A. Goddard A.C. Argent Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains J Infect Dis 1997 in press
45. N.B. Loffell L.N. Rossi H. Mumenthaler The Landrey-Guillain-Barré syndrome: Complications, prognosis, and natural history in 123 cases J Neurol Sci 33 1977 71 79
46. G.J. Luijckx J. Vles M. de Baets Guillain-Barré syndrome on mother and newborn child Lancet 349 1997 27
47. G.A. MacGregor Familial Guillain-Barré syndrome Lancet 2 1965 1296
48. R.E. Mandrell M.A. Apicella Lipo-oligosaccharides (LOS) of mucosal pathogens: Molecular mimicry and host-modification of LOS Immunobiology 187 1993 382 402
49. G.M. McKhann D.R. Cornblath J.W. Griffin Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China Ann Neurol 33 1993 333 342
50. B. Mishu A.A. Amjad C.L. Koski Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome Ann Intern Med 118 1993 947 953
51. B. Mishu M.J. Blaser The role of Campylobacter jejuni infection in the initiation of Guillain-Barré syndrome Clin Infect Dis 17 1993 104 108
52. B. Mishu C.M. Patton M.J. Blaser Microbiologic characteristics of Campylobacter jejuni strains isolated from patients with Guillain-Barré syndrome. Infectious Diseases Society of America 1993, New Orleans, LA [abstract number 45] Clin Infect Dis 17 1993 538
53. C.K. Molnar J. Mertsola M. Erkko Guillain-Barré syndrome associated with Campylobacter infection Br Med J 285 1982 652
54. A.P. Moran Structure-bioactivity relationships of bacterial endotoxins J Toxicol Toxin Rev 14 1994 47 83
55. A.P. Moran E.T. Rietschel T.U. Kosunene Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N- acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose J Bacteriol 173 1991 618 626
56. E. Nobile-Orazio M. Carpo N. Meucci Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies J Neurol Sci 109 1992 200 206
57. W. Osler The Principles and Practice of Medicine 1892 Appleton New York
58. W.M. Pryor J.S. Freiman M.A. Gillies Guillain-Barré syndrome associated with Campylobacter infection Aust NZ J Med 14 1984 687 688
59. R.H. Quarles A.A. Ilyas H.J. Willison Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome Ann Neurol 27 suppl 1990 S48 S52
60. M. Ramos-Alvarez L. Bessudo A. Sabin Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy: Acute paralytic disease in Mexican children, neurologically distinguishable from Landry-Guillain-Barré syndrome JAMA 207 1969 1481 1492
61. H. Rantala M. Uhari M. Niemela Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome Arch Dis Child 66 1991 706 708
62. J.H. Rees N.A. Gregson R.A.C. Hughes Anti-ganglioside antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection Ann Neurol 38 1995 809 816
63. J.H. Rees S.E. Soudain N.A. Gregson Campylobacter jejuni infection and Guillain-Barré syndrome N Engl J Med 333 1995 1374 1379
64. J.H. Rees R.W. Vaughan E. Kondeatis HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection J Neuroimmunol 62 1995 53 57
65. K.M. Rhodes A.E. Tattersfield Guillain-Barré syndrome associated with Campylobacter infection Br Med J 285 1982 173 174
66. A.H. Ropper Campylobacter diarrhea and Guillain-Barré syndrome Arch Neurol 45 1988 655 656
67. A.H. Ropper Severe acute Guillain-Barré syndrome Neurology 36 1986 429 432
68. A.H. Ropper E.F.M. Wijdicks B.T. Trumax Guillain-Barré syndrome 1991 FA Davis Philadelphia 1930
69. S. Salloway L.A. Mermel M. Seamans Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3 Infect Immun 64 1996 2945 2949
70. E.A. Sanders A.C. Peters J.W. Gratana Guillain-Barré syndrome after varicella-zoster infection: Report of two cases J Neurol 234 1987 437 439
71. M. Saunders M. Rake Familial Guillain-Barré syndrome Lancet 2 1965 1106 1107
72. Seattle-King County Department of Public Health Surveillance of the flow of Salmonella and Campylobacter in a community 1984 Communicable Disease Control Section, Seattle-King County Department of Public Health Seattle
73. I.L. Simone P. Annunziata D. Maimone Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy J Neurol Sci 114 1993 49 55
74. G.S. Smith M.J. Blaser Fatalities associated with Campylobacter jejuni infections JAMA 1985 2873 2875
75. B. Speed J. Kaldor P. Cavanagh Guillain-Barré syndrome associated with Campylobacter jejuni enteritis J Infect 8 1984 85 86
76. B.R. Speed J. Kaldor J. Watson Campylobacter jejuni/Campylobacter coli- associated Guillain-Barré syndrome: immunoblot confirmation of the serologic response Med J Aust 147 1987 13 16
77. A. Svedhem B. Kaijser Campylobacter fetus subspecies jejuni: A common cause of diarrhea in Sweden J Infect Dis 142 1980 353 359
78. L. Svennerholm P. Fredman Antibody detection in Guillain-Barré syndrome Ann Neurol 27 suppl 1990 S36 S40
79. R.V. Tauxe Epidemiology of Campylobacter jejuni infections in the United States and other industrialized countries I. Nachamkin M.J. Blaser L.S. Tompkins Campylobacter jejuni: Current Strategy and Future Trends 1992 American Society of Microbiology Washington, DC 9 19
80. R.V. Tauxe N. Hargrett-Bean C.M. Patton Campylobacter isolates in the United States 1982–1986 MMWR 37 No. SS-2 1988 1 14
81. C.A. Thornton A.S. Latif J.C. Emmanuel Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe Neurology 41 1991 812 815
82. N. Tsukada C.S. Koh A. Inoue Demyelinating neuropathy associated with hepatitis B virus infection J Neurol Sci 77 1987 203 216
83. E.N. Valenciano F. Perez-Gallardo A. Gonzales Outbreak of paralytic illness of unknown etiology in Albecete, Spain Am J Epidemiol 94 1971 450 456
84. L.H. Van den Berg J. Marrink A.E.J. deJager Anti-GM1 antibodies in patients with Guillain-Barré syndrome J Neurol Neurosurg Psychiatry 55 1992 8 11
85. F.G.A. van der Meche P.I.M. Schmitz the Dutch Guillain-Barré Study Group A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome N Engl J Med 326 1992 1123 1129
86. L.H. Visser F.G.A. van der Meche P.A. van Doorn Guillain-Barré syndrome without sensory loss (acute motor neuropathy): A subgroup with specific clinical, electrodiagnostic, and laboratory features Brain 118 1995 841 847
87. F.J. Vriesendorp B. Mishu M.J. Blaser Serum antibodies to GM1, Gd1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: Correlation and prognosis Ann Neurol 34 1993 130 135
88. H.J. Willison J. Veitch G. Patterson Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside J Neurol Neurosurg Psychiatry 56 1993 204 206
89. J.B. Winer D. Briggs K. Welsh HLA antigens in the Guillain-Barré syndrome J Neuroimmunol 18 1988 13 16
90. J.B. Winer R.A.C. Hughes C. Osmond A prospective study of acute idiopathic neuropathy. I: Clinical features and their prognostic value J Neurol Neurosurg Psychiatry 51 1988 605 612
91. J.B. Winer R.A.C. Hughes M.J. Anderson A prospective study of acute idiopathic neuropathy. II: Antecedent events J Neurol Neurosurg Psychiatry 51 1988 613 618
92. S.J. Wroe L.D. Blumhardt Polyneuritis with cranial nerve involvement following Campylobacter jejuni infection J Neurol Neurosurg Psychiatry 48 1985 593
93. N. Yuki S. Sato S. Fujimoto Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome Muscle Nerve 15 1992 968 969
94. N. Yuki S. Handa T. Tai Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome J Neurol Sci 130 1995 112 116
95. N. Yuki S. Sato T. Itoh HLA-B35 and acute axonal polyneuropathy following Campylobacter infection Neurology 41 1991 1561 1563
96. N. Yuki T. Taki F. Inagaki A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure J Exp Med 178 1993 1771 1775
97. N. Yuki T. Taki M. Takahashi Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope Infect Immun 62 1994 2101 2103
98. N. Yuki T. Taki M. Takahashi Molecular mimicry between GQ1b ganglioside and lipopolysaccharide of Campylobacter jejuni isolated from patients with Fisher's syndrome Ann Neurol 36 1994 791 793
99. N. Yuki Y. Tsujino Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis J Pediatrics 1995 162
100. N. Yuki M. Yamada S. Sato Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome Muscle Nerve 16 1993 642 647
101. N. Yuki H. Yoshino S. Sato Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis Neurology 40 1990 1900 1902
102. N. Yuki H. Yoshino S. Sato Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies Muscle Nerve 15 1992 899 903